The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa

European Journal of Pharmaceutical Sciences

Volumn 20, Issue 1, 2003, Pages 73-81

  De Campos, Angela M ^a   Sánchez, Alejandro ^a   Gref, Ruxandra ^b   Calvo, Pilar ^a   Alonso, María J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIV PARIS SUD   (France)

Author keywords

Chitosan; Corneal transport; Nanocapsules; Ocular drug delivery; Polyethylene glycol

Indexed keywords

DEPOSITION; ELECTROSTATICS; INTERFACES (MATERIALS); POLYETHYLENE GLYCOLS;

DRUG CARRIERS;

DRUG PRODUCTS;

CHITOSAN; COPOLYMER; DRUG CARRIER; FLUORESCENT DYE; MACROGOL; NANOCAPSULE; POLYCAPROLACTONE; POLYMER; RHODAMINE;

ACCELERATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TRANSPORT; CHEMICAL COMPOSITION; COLLOID; COMPARATIVE STUDY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORNEA; CORNEA EPITHELIUM; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TRANSPORT; EYE; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MALE; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; SURFACE PROPERTY;

EID: 0042834363     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(03)00178-7     Document Type: Article

References (21)

1. Artursson P., Lindmark T., Davis S.S., Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11:1994;1358-1361.
2. Barbault-Foucher S., Gref R., Russo P., Guechot J., Bochot A. Design of poly-e-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery. J. Control. Rel. 83:2002;365-375.
3. Calvo P., Thomas C., Alonso M.J., Vila-Jato J.L., Robinson J.R. Study of the mechanism of interaction of poly-e-caprolactone nanocapsules with the cornea by confocal laser scanning microscopy. Int. J. Pharm. 103:1994;283-291.
4. Calvo P., Alonso M.J., Vila-Jato J.L., Robinson J.R. Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J. Pharm. Pharmacol. 48:1996;1147-1152.
5. Calvo P., Vila-Jato J.L., Alonso M.J. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int. J. Pharm. 153:1997;41-50.
6. Calvo P., Remuñan C., Vila Jato J.L., Alonso M.J. Development of positively charged colloidal drug carriers: chitosan-coated polyester nanocapsules and submicron emulsions. Colloid. Polym. Sci. 275:1997;46-53.
7. De Campos A., Sanchez A., Alonso M.J. Chitosan nanoparticles: a new vehicle for the improvement of the ocular retention of drugs. Application to cyclosporin A. Int. J. Pharm. 224:2001;159-168.
8. Dodane V., Khan M.A., Merwin J.R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 182:1999;21-32.
9. Felt O., Furrer P., Mayer J.M., Plazonnet B., Buri P., Gurny R. Topical use of chitosan in opthalmology: tolerance assessment and evaluation of precorneal retention. Int. J. Pharm. 180:1999;185-193.
10. Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., Benita S. Nanocapsules formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55:1989;R1-R4.
11. Gref R., Lück M., Quellec P., Marchand M., Dellacherie E., Harnish S., Blunk T., Müller R.H. 'Stealth' core-corona nanoparticles surface modified by polyethylene glycol (PEG): influence of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloid Surf. B: Biointerfaces. 18:2000;301-313.
12. Hassan E.E., Gallo J.M. A simple rheological method for the in vivo assessment of mucin-polymer bioadhesive bond strength. Pharm. Res. 7:1990;491-495.
13. Hirano S., Seino H., Akiyama Y., Nonaka I. Biocompatibility of chitosan by oral and intravenous administration. Polym. Eng. Sci. 59:1989;897-901.
14. Koch M.A., Dodane V., Khan M.A., Merwin J.R. Chitosan induced effects on epithelial morphology as seen by confocal scanning microscopy. Scanning. 20:1998;262-263.
15. Lehr C.M., Bowstra J.A., Schacht E.H., Junginger H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78:1992;43-48.
16. Levy M.Y., Benita S. Drug release from submicronized O/W emulsion: a new in vitro kinetic evaluation model. Int. J. Pharm. 66:1990;29-37.
17. Losa C., Marchal-Heussler L., Orallo F., Vila-Jato J.L., Alonso M.J. Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol. Pharm. Res. 10:1993;80-87.
18. Pangburn S.H., Trescony P.V., Heller J. Lysozyme degradation of partially deacetylated chitin, its films and hydrogels. Biomaterials. 3:1982;105-108.
19. Rohen J.W., Lutjen-Drecoll E. Functional morphology of the conjunctiva. Lemp M.A., Marqquardt R. The Dry Eye. A Comprehensive Guide. 1992;35-63 Springer, Berlin.
20. Tobio M., Gref R., Sanchez A., Langer R., Alonso M.J. Stealth PEG-PLA nanoparticles as protein carriers for nasal administration. Pharm. Res. 15:1998;270-275.
21. Tobio M., Sanchez A., Vila A., Soriano I., Evora C., Vila-Jato J.L., Alonso M.J. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloid Surf. B: Biointerfaces. 18:2000;315-323.